SCHEMBL17385281

SCHEMBL17385281

Cc1nc2cc(CCC(=O)O)ccc2o1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.51
FFAR1 O14842 7/20 0.50
RAB9A P51151 5/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
STAT1 P42224 1/20 0.47
POLB P06746 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HTT P42858 1/20 0.45
LMNA P02545 1/20 0.43
S1PR1 P21453 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3807350 0.85 GAA (0.69) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL17385279 0.83 CYP4F2 (0.51) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL17385280 0.83 RAB9A (0.53) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL23582810 0.82 FFAR1 (0.50) GAAFFAR1KDM4EMAPTLMNA
SCHEMBL3087532 0.80 GAA (0.52) GAAFFAR1RAB9ANPC1SMN1; SMN2
SCHEMBL10315086 0.80 GAA (0.50) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL17221544 0.78 GAA (0.51) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL14740938 0.77 POLB (0.48) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL2307975 0.76 PTPRA (0.58) GAARAB9AL3MBTL1NPC1SMN1; SMN2
SCHEMBL8180377 0.76 RAB9A (0.56) GAARAB9AL3MBTL1NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153756-A1 ANTI-INFECTIVE COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2022-05-19 US disclosed
US-20170121349-A1 Anti-Infective Compounds INSTITUT PASTEUR KOREA (KR) 2017-05-04 US disclosed
WO-2015193506-A1 ANTI-INFECTIVE COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2015-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153756-A1 ANTI-INFECTIVE COMPOUNDS RABGGTB, ELANE, SERPINB1 GAA 949/4885FFAR1 4298/4885RAB9A 1091/4885
US-20170121349-A1 Anti-Infective Compounds FNTB, LSS, PGLS GAA 540/4885FFAR1 4026/4885RAB9A 594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.